Explain the benefits and risks of systemic and targeted therapies based on the latest evidence for adults with NF1-PN within a multimodal care pathway. Describe approaches for monitoring response and managing adverse effects in adults receiving systemic or targeted treatment for NF1-PN. Evaluate pain, functional and quality-of-life outcomes to inform shared decision-making and multidisciplinary care plans for adults with NF1-PN.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
No specific specialties targeted.
Address:
- 124 S. Franklin Street
Pricing
89% of listed courses are free
25 of 28 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiothoracic Surgery
- Critical Care Medicine
- Endocrinology, Diabetes & Metabolism
- Gastroenterology
- Gastrointestinal Surgery
- General Surgery
- Gynecologic Oncology
- Head & Neck Surgery
- Hematology
- Medical Genetics & Genomics
- Medical Oncology
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Orthopaedic Trauma
- Pulmonary Disease
- Surgical Critical Care
- Surgical Oncology
- Thoracic Surgery
- Cardio-Vascular
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pathology & Lab
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 0.75 credits
- Commercial Support
-
ReleasedSep 30, 2026
-
Last day to claim creditOct 1, 2027 12 months left
-
Creative Educational Concepts, Inc. Targeting the Pathway: Evolving Roles of MEK Inhibitors in NF1-Associated PN
-
Neurofibromatosis Network +1 ReiNForcing Care Pathways in NF1-PN: Solutions to Improve Outcomes Across the Patient Journey With MEK Inhibition and Shared-Care Models
-
Medscape, LLC Beyond the Tumor: A Comprehensive Approach to Adult Neurofibromatosis 1-Associated Plexiform Neurofibromas
-
touchIME, USF Health Delivering state-of-the-art care for GEP-NETs: Evidence-based strategies for PRRT
-
touchIME, USF Health Management of neurofibromatosis: Optimizing treatment and care from childhood to adult life
-
touchIME, USF Health Evolving Paradigms in PNH Management: Interpreting the Latest Data
